Journals / Turkish Journal of Urology / 2022 / Cilt: 48 - Sayı: 3

Acellular Tissue Engineered Pericardial Patch Urethroplasty: A New Horizon of Substitution Urethroplasty

Pages
222–228
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Acellular tissue-engineered pericardial patch substitution urethroplasty can be a useful alternative to autologous tissue substitution, especially where the buccal mucosal graft is unavailable for urethroplasty.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Buccal mucosal graft is the best autologous material for substitution urethroplasty.
📊
Key Findings & Data:Material and methods: A total of 22 patients underwent acellular tissue-engineered pericardial patch substi- tution urethroplasty using dorsolateral onlay technique for long segment urethral stricture, for a period of two years.
💡
Conclusion & Impact:Conclusion: Acellular tissue-engineered pericardial patch substitution urethroplasty can be a useful alternative to autologous tissue substitution, especially where the buccal mucosal graft is unavailable for urethroplasty.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: Buccal mucosal graft is the best autologous material for substitution urethroplasty. However, in cases where buccal mucosa is unavailable, a non-autologous tissue like acellular tissue-engineered pericar- dial patch can be very helpful. Our study is a small approach regarding the success and durability of acellular tissue-engineered pericardial patch as a substitution tissue in urethroplasty. Material and methods: A total of 22 patients underwent acellular tissue-engineered pericardial patch substi- tution urethroplasty using dorsolateral onlay technique for long segment urethral stricture, for a period of two years. Observations and comparison were made in terms of postoperative change in maximum urinary flow rate (Qmax), resolution of obstructive lower urinary tract symptoms, improvement in retrograde urethrogram and complications encountered, with buccal mucosal graft urethroplasty as a historical control. Results: Out of these 22 patients, 18 patients had successful outcomes considering maximum flow rate (Qmax) > 10 mL/s on uroflowmetry, resolved obstructive lower urinary tract symptoms, and normal postoperative retrograde urethrogram, whereas four patients were considered a failure because of Qmax <10 mL/s, unre- solved obstructed lower urinary tract symptoms and recurrence of urethral stricture on retrograde urethro- gram and development of urethrocutaneous fistula. Conclusion: Acellular tissue-engineered pericardial patch substitution urethroplasty can be a useful alternative to autologous tissue substitution, especially where the buccal mucosal graft is unavailable for urethroplasty.

🔖

Cite This Article

CHOUDHURY, S., KHARE, E., PAL, D. K. (2022). Acellular Tissue Engineered Pericardial Patch Urethroplasty: A New Horizon of Substitution Urethroplasty. Turkish Journal of Urology, Cilt: 48 - Sayı: 3, 222–228. https://ajindex.com/articles/413273

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Potts BA, Belsante MJ, Peterson AC. Intraurethral steroids are a safe and effective treatment for stricture disease in patients with biopsy proven lichen sclerosus. J Urol. 2016;195(6):1790-1796. [CrossRef] 2. Dey RK, Khan I, Khan D. Study of intraurethral instillation of tacrolimus for urethral involvement following lichen sclerosus. Int J Sci Stud. 2017;5:204-208. 3. Andrich DE, Mundy AR. Urethral strictures and their surgical treatment. BJU Int. 2000;86(5):571-580. [CrossRef] 4. Mundy AR. Management of urethral strictures. Postgrad Med J. 2006;82(970):489-493. [CrossRe]. Chee JY, Durai P, Wu FM, Tiong HY. Bladder repair following iatrogenic cystotomy in irradiated small capacity bladders. Singa- pore Med J. 2015;56(3):e49-e52. [CrossRef] 6. Li X, Guo Y, Ziegler KR, et al. Current usage and future directions for the bovine pericardial patch. Ann Vasc Surg. 2011;25(4):561- 568. [CrossRef] 7. Vesely I, Mako WJ. Comparison of the compressive buckling of porcine aortic valve cusps and bovine pericardium. J Heart Valve Dis. 1998;7(1):34-39. 8. Cheng L, Li S, Wang Z, Huang B, Lin J. A brief review on anterior urethral strictures. Asian J Urol. 2018;5(2):88-93. [CrossRef] 9. Kulkarni S, Barbagli G, Sansalone S, Lazzeri M. One-sided ante- rior urethroplasty: a new dorsal onlay graft technique. BJU Int. 2009;104(8):1150-1155. [CrossRef] 10. Chapple C, Andich D, Atala A, et al. SIU/ICUD Consultation on urethral strictures: the management of anterior urethral stricture disease using substitution urethroplasty. Urol. 2014;83:31-47. 11. Fiala R, Vidlar A, Vrtal R, Belej K, Student V. Porcine small intes- tinal submucosa graft for repair of anterior urethral strictures. Eur Urol. 2007;51(6):1702-1708. [CrossRef] 12. Donkov II, Bashir A, Elenkov CHG, Panchev PK. Dorsal onlay augmentation urethroplasty with small intestinal submucosa: mod- ified Barbagli technique for strictures of the bulbar urethra. Int J Urol. 2006;13(11):1415-1417. [CrossRef] 13. Li X, Guo Y, Ziegler KR, et al. Current usage and future directions for the bovine pericardial patch. Ann Vasc Surg. 2011;25(4):561- 568. [CrossRef] 14. Novick AC, Straffon RA, Koshino I, Banowsky LH, Levin H, Kambic H. Experimental bladder substitution using a biodegradablegraft of natural tissue. J Biomed Mater Res. 1978;12(2):125-147. [CrossRef] 15. Kambic H, Kay R, Chen JF, Matsushita M, Harasaki H, Zilber S. Biodegradable pericardial implants for bladder augmentation: a 2.5-year study in dogs. J Urol. 1992;148(2 Pt